BTG

In 1948 was created BTG, which is appeared as Corporate Investor. The venture was found in Europe in United Kingdom. The main department of described Corporate Investor is located in the London.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the BTG, startups are often financed by Versant Ventures, River Cities Capital Funds, Prolog Ventures. The meaningful sponsors for the fund in investment in the same round are Windamere Venture Partners, Wellcome Trust, Teknoinvest. In the next rounds fund is usually obtained by BioAdvance, Wellcome Trust, SR One.

Among the most popular portfolio startups of the fund, we may highlight Veran Medical Technologies, Avera Pharmaceutical, QuNano. We can highlight the next thriving fund investment areas, such as Developer Platform, Health Care. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in some founders of portfolio startups.

The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2008. Considering the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2004. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this BTG performs on 16 percentage points less the average number of lead investments.

Notable deals

Review

• No reviews are submitted yet.